Searched for
MABPHARM
Reliance Life Sciences ends deal with Epirus for Remicade copiesJanssen’s Remicade is the third biggest pharmaceutical brand globally with sales exceeding $8 billion last year.- Hamsons buys 21% stake in Okasa PharmceuticalsWhile Cipla paid Rs 29 crore for Okasa’s facility in Goa, it bought another plant, owned by Okasa Pharma, located in Satara for Rs 71.93 cr...
- Cipla slips over 2% as Q2 results disappointsIts consolidated net profit fell to Rs 298.7 crore, donw 16.6 per cent, against Rs 358 crore, Year-on-Year while net sales grew to Rs 2629....
- Cipla Q2 net profit at Rs 299 croreCipla today posted a consolidated net profit of Rs 298.68 crore for the quarter ended September 30, 2014, on account of robust sales in dom...
- Ten stocks in focus in Friday morning tradeIndian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus today.
- Cipla scouting for outside talent, focus on Africa deliver the goodsThe company’s improved performance over the last four quarters is a testimony to the fact that these changes are paying off.
- Cipla: Move to enter biotech looks opportuneCipla’s latest move to grow through acquisitions comes at a time when the company has been growing at lower than the industry growth rate f...
Load More